# The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

> **NCT00002437** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 48 (—)

## Conditions studied

- Cytomegalovirus Retinitis
- HIV Infections

## Interventions

- **DRUG:** Cidofovir
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT00002437
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 48 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002437, "The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*